Ryman Healthcare reports loss amid reset, equity raise

** Ryman Healthcare (NZX:RYM) reported a net loss after tax (NPAT) of NZD 436.8 million for the year ended March 31, 2025, impacted by accounting changes and market pressures. To address these challenges, the company successfully completed a NZD 1 billion equity raise. Revenue grew by 10% to NZD 760.7 million, while operating EBITDAF increased to NZD 45.5 million. The equity injection reduced net interest-bearing debt to NZD 1.665 billion, lowering gearing to 28.1%. Ryman delivered a record 950 new units and beds, bringing the total to 49 operational villages. The company has suspended dividends and will review its capital management policy in FY26. Naomi James commenced as CEO in November 2024, undertaking a transformation program, with a focus on releasing cash, improving business performance, and disciplined growth. The group also has a climate-related disclosures report.